24. September 2023 | Amphetamine
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.
Mitchell, J.M., Ot’alora G., M., van der Kolk, B. et al.
Nat Med (2023). doi.org/10.1038/s41591-023-02565-4
https://www.nature.com/a...